PCSK-9 inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PCSK-9 inhibitor (unspecified), covering 2025-06-10 to 2025-06-10. Get the full timeline:
Most recent: Clinical Trial Update: PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy [Phase 2]